Correlation Between Tata Consultancy and Biofil Chemicals

Can any of the company-specific risk be diversified away by investing in both Tata Consultancy and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tata Consultancy and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tata Consultancy Services and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Tata Consultancy and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tata Consultancy with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tata Consultancy and Biofil Chemicals.

Diversification Opportunities for Tata Consultancy and Biofil Chemicals

0.16

Correlation Coefficient

Tata Consultancy  Biofil Chemicals

Average diversification

The 3 months correlation between Tata and Biofil is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Tata Consultancy Services and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Tata Consultancy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tata Consultancy Services are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Tata Consultancy i.e., Tata Consultancy and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Tata Consultancy and Biofil Chemicals

Assuming the 90 days trading horizon Tata Consultancy Services is expected to under-perform the Biofil Chemicals. But the stock apears to be less risky and, when comparing its historical volatility, Tata Consultancy Services is 3.39 times less risky than Biofil Chemicals. The stock trades about -0.05 of its potential returns per unit of risk. The Biofil Chemicals Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  6,369  in Biofil Chemicals Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  225.00  from holding Biofil Chemicals Pharmaceuticals or generate 3.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tata Consultancy Services  vs.  Biofil Chemicals Pharmaceutica

Tata Consultancy Services

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tata Consultancy Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Biofil Chemicals Pha

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Biofil Chemicals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Tata Consultancy and Biofil Chemicals

The main advantage of trading using opposite Tata Consultancy and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tata Consultancy position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.

The idea behind Tata Consultancy Services and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.